Changes in Beneficial Ownership · 4
Transcat, Inc.
TRNSNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
form4.xml
Filing details
- Report period
- 2026-09-09
- Issuer
- TRANSCAT INC
- Issuer CIK
- 0000099302
- Trading symbol
- TRNS
Reporting owner 1
- Name
- Dominach Oksana S.
- Reporting owner CIK
- 0001791707
- Relationship
- Director
- Address
- C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER, NY, 14624
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock, $.50 par value | 2026-09-10 | M · Form 4 | 1,587 | A | 0[F1] | 5,933 | D |
Table key
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
- A
- Acquired
- D
- Direct
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock Units | 0[F1] | 2026-09-09 | A · Form 4 | 1,671 | A | 0 | [F2] | [F2] | Common Stock, $.50 par value | 1,671 | 1,671 | D |
| Restricted Stock Units | 0[F1] | 2026-09-10 | M · Form 4 | 1,587 | D | 0 | [F3] | [F3] | Common Stock, $.50 par value | 1,587 | 0 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
Footnotes
Signature 1
- Signed
- /s/ Kristina L. Johnston, Attorney-in-Fact for Oksana S. Dominach
- Date
- 2026-09-10
Company context
Transcat, Inc. is a leading provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing best-in-class services and products to highly regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical device, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. Transcat provides periodic on-site services, mobile calibration services, pickup and delivery, in-house services at its Calibration Service Centers strategically located across the United States and Internationally. In addition, Transcat operates calibration labs in imbedded customer-site locations. The breadth and depth of measurement parameters addressed by Transcat’s ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry.